BIOMAT Database Logo BIOMAT Database Logo

Development of a dosage scheme for simultaneous intravenous and oral administration of mexiletine. 1977

A C Paalman, and J Siebelink, and J C Roos, and A J Dunning

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008801 Mexiletine Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties. KO-1173,KO1173,KOE-1173,Mexiletene,Mexiletine Hydrochloride,Mexitil,Mexitil PL,Mexityl,Novo-Mexiletine,KO 1173,KOE 1173,KOE1173,Novo Mexiletine
D011437 Propylamines Derivatives of propylamine (the structural formula NH2CH2CH2CH3).
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A C Paalman, and J Siebelink, and J C Roos, and A J Dunning
Oral dosage schedules for mexiletine.
January 1977, Postgraduate medical journal,
A C Paalman, and J Siebelink, and J C Roos, and A J Dunning
A schedule for combined intravenous and oral dosing with mexiletine.
January 1979, The Journal of international medical research,
A C Paalman, and J Siebelink, and J C Roos, and A J Dunning
[Dosage for intravenous oxytocin administration].
January 1955, Duodecim; laaketieteellinen aikakauskirja,
A C Paalman, and J Siebelink, and J C Roos, and A J Dunning
Simultaneous modelling of mexiletine and hydroxy-methyl-mexiletine data after single- and multiple-dose administration of a sustained-release mexiletine formulation.
October 1992, Biopharmaceutics & drug disposition,
A C Paalman, and J Siebelink, and J C Roos, and A J Dunning
Efficacy of oral mexiletine therapy at a 12-h dosage interval.
February 1990, Chest,
A C Paalman, and J Siebelink, and J C Roos, and A J Dunning
[Development of semisolid dosage form of clonazepam for oral cavity administration].
January 2010, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
A C Paalman, and J Siebelink, and J C Roos, and A J Dunning
The development of intravenous mexiletine dose regimes.
January 1977, Postgraduate medical journal,
A C Paalman, and J Siebelink, and J C Roos, and A J Dunning
A trial of intravenous and oral mexiletine in acute myocardial infarction.
January 1984, European journal of clinical pharmacology,
A C Paalman, and J Siebelink, and J C Roos, and A J Dunning
Intravenous immune globulin: dosage and administration.
January 1987, Pharmacotherapy,
A C Paalman, and J Siebelink, and J C Roos, and A J Dunning
[Pharmacokinetics of mexiletine and its hydroxymethyl metabolite after intramuscular and intravenous administration of mexiletine in healthy subjects].
January 1987, Therapie,
Copied contents to your clipboard!